Skip to content Skip to navigation

Management of sympathetic ophthalmia with the fluocinolone acetonide implant.

TitleManagement of sympathetic ophthalmia with the fluocinolone acetonide implant.
Publication TypeJournal Article
Year of Publication2009
AuthorsMahajan, Vinit B., Gehrs Karen M., Goldstein Debra A., Fischer David H., Lopez Juan S., and Folk James C.
JournalOphthalmology
Volume116
Issue3
Pagination552-557.e1
Date Published2009 Mar
KeywordsAdult, Aged, Drug Implants, Female, Fluocinolone Acetonide, Follow-Up Studies, Glucocorticoids, Humans, Immunosuppressive Agents, Intraocular Pressure, Male, Middle Aged, Ophthalmia, Sympathetic, Retrospective Studies, Treatment Outcome, Visual Acuity
Abstract

We examined whether implantation of the fluocinolone acetonide (Retisert) implant achieved control of inflammation and a reduced need for oral corticosteroids or immunosuppressives in patients with sympathetic ophthalmia (SO).

Alternate JournalOphthalmology